Certified by Founder
Lodge
CatalYm GmbH
start up
Germany
- Martinsried, Bayern
- 16/07/2024
- Series D
- $150,000,000
Developing innovative immunotherapies to transform cancer patients’ lives by engaging their own immune systems.
- Industry Biotechnology Research
- Website https://www.catalym.com/
- LinkedIn https://www.linkedin.com/company/catalym/
Related People
Phil L'HuillierFounder
United Kingdom -
Greater London, England
Specialties: CEO, Leadership, Corporate Development & strategy, Clinical Development, Business Development in biotechnology and pharmaceutical sectors
Ciphero | $2,500,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)
StretchSense | $2,300,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ethereal Exploration Guild | $21,000,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)